Gene: ANKIB1
Official Full Name: ankyrin repeat and IBR domain containing 1provided by HGNC
Gene Summary: Predicted to enable ubiquitin conjugating enzyme binding activity and ubiquitin protein ligase activity. Predicted to be involved in ubiquitin-dependent protein catabolic process. Predicted to be part of ubiquitin ligase complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21730 | ANKIB1 Knockout cell line (HeLa) | Human | ANKIB1 | 1:3~1:6 | Negative | Online Inquiry |
KO21731 | ANKIB1 Knockout cell line (HCT 116) | Human | ANKIB1 | 1:2~1:4 | Negative | Online Inquiry |
KO21732 | ANKIB1 Knockout cell line (HEK293) | Human | ANKIB1 | 1:3~1:6 | Negative | Online Inquiry |
KO21733 | ANKIB1 Knockout cell line (A549) | Human | ANKIB1 | 1:3~1:4 | Negative | Online Inquiry |
ANKIB1 Gene Knockout Cell Lines represent a breakthrough in the field of molecular biology, specifically designed to facilitate the study of the ANKIB1 gene's role in cellular processes. These cell lines are created using advanced CRISPR-Cas9 gene editing technology, which allows for the precise deletion of the ANKIB1 gene in relevant cellular models. By generating these knockout cell lines, researchers can explore the functional dynamics of ANKIB1 without the confounding effects of wild-type gene expression.
The primary function of the ANKIB1 Gene Knockout Cell Lines is to provide a robust model for investigating the gene's involvement in critical biological pathways, such as cellular signaling, proliferation, and differentiation. These knockout models allow for in-depth analysis of gene function using techniques such as Western blotting, qPCR, and high-throughput screening. Researchers can assess how the absence of ANKIB1 affects cellular responses, enabling them to delineate the gene's contribution to health and disease.
In terms of scientific importance, these cell lines are invaluable in both research and clinical settings. They can significantly advance our understanding of conditions related to ANKIB1 dysregulation, including specific cancers and neurological disorders. By elucidating these mechanisms, researchers can identify potential therapeutic targets, paving the way for innovative treatment strategies.
What sets ANKIB1 Gene Knockout Cell Lines apart from alternatives is their specificity and customizable nature, allowing for streamlined experimentation and reproducibility. Unlike less targeted approaches, these cell lines minimize off-target effects and provide precise control over experimental conditions, making them indispensable for researchers aiming for high-quality data.
For researchers and clinicians focused on gene function and disease mechanism exploration, these knockout cell lines offer a powerful tool that drives innovation and discovery. Investing in ANKIB1 Gene Knockout Cell Lines equips scientists with an unparalleled resource for advancing genetic and cellular research.
As a provider of cutting-edge biological products, our company's expertise in cellular models ensures that each product is crafted to meet the highest standards of scientific rigor and reliability, empowering the research community to unlock new possibilities in gene function studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.